Artiva Biotherapeutics, Inc.
Associate Director/Director, Medical Communications
Artiva Biotherapeutics, Inc., San Diego, California, United States, 92121
About Artiva:
Artiva is clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers.
Artiva's lead product candidate, AlloNK, is a non-genetically modified, off-the-shelf, allogeneic, cryopreserved NK cell therapy designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell depletion and to be administered in the community setting. Unlike CAR-T and any genetically modified cell therapy, AlloNK is a non-genetically modified NK cell therapy candidate and has not shown any secondary malignancies in our clinical trials, which is a benefit in an autoimmunity setting. Using the company's proprietary cell therapy manufacturing platform, Artiva can generate thousands of doses of cryopreserved, infusion-ready AlloNK cells from a single cord blood unit. The FDA has granted Fast Track designation to AlloNK in combination with rituximab or obinutuzumab for the treatment of class III or IV lupus nephritis, and AlloNK in combination with rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma of B-cell origin (B-NHL).
AlloNK, is currently being evaluated in combination with B-cell targeted mAbs in
patients with autoimmune diseases and cancers, such as lupus nephritis, SLE, rheumatoid arthritis, pemphigus vulgaris, the ANCA-associated vasculitis subtypes GPA/MPA, and B-NHL. In addition, we are also pursuing AlloNK and our CAR-NK product candidates in multiple indications through collaborator-funded trials. Artiva's cell therapy manufacturing platform incorporates cell expansion and activation technology developed by Artiva's strategic partner, GC Cell Corporation, a member of the GC family of companies, a leading healthcare company in Korea.
Artiva is headquartered in San Diego and backed by leading venture investors including 5AM Ventures, RA Capital Management and venBio Partners.
For more information, visit www.artivabio.com.
Job Summary:
The Associate Director/Director of Medical Communications oversees the strategic planning and execution of all medical communication activities within Artiva.
Key Responsibilities:Develop strategies for effective scientific communication, ensuring compliance with industry standards and fostering scientific exchange.Drive the development and execution of high-quality medical publications, scientific content, medical education, medical information, and congress presentations.Act as a subject matter expert in communication landscape, HCP preferences, publication planning, data disclosure, and represent the organization's scientific communications externally.Demonstrate strong business acumen in managing the Medical Communications budget and allocating resources to highest business priorities.Collaborate effectively with internal and external disease-area experts to ensure high-quality data analysis, interpretation, and communication planning.Foster collaborative relationships with academic and clinical experts, medical associations, publishers, and other relevant stakeholders.Partner with third-party vendors to balance internal and external execution effectively.
Qualifications & Experience:Advanced scientific degree (PharmD, PhD.) preferred, with 7-10 years of experience in the pharmaceutical/healthcare industry focusing on medical communications.Experience in the autoimmunity therapeutic area preferred.Ability to communicate complex scientific concepts clearly through both written and oral channels; detail-oriented and data-driven.Proven track record in managing compliance requirements for medical education activities.Strong organizational, communication, facilitation, and interpersonal skills.Ability to analyze and interpret trial data effectively.Willingness and ability to travel as needed.
Why you should apply:
We have a fantastic team and philosophy! We are passionate - we deeply care about our team, our science, and improving the lives of cancer patients. We are tenacious - laser-focused on our mission and undeterred in our commitment to deliver life-saving medicines for cancer patients. We are innovative - pushing into new frontiers for patient benefit. We are transparent - believers in flat, accessible, and open communication paths. We are inclusive - committed to the diversity of our team and ensuring that all voices are heard.
In addition to a great culture, we offer:• A beautiful facility• An entrepreneurial, highly collaborative, and innovative environment• Comprehensive benefits, including:Medical, Dental, and VisionGroup Life InsuranceLong Term Disability (LTD)401(k) Retirement PlanEmployee Assistance Program (EAP)Flexible Spending Account (FSA)Paid Time Off (PTO)Company paid holidays, including the year-end holiday weekOur recognition program, Bonus.ly, is where you can trade in points earned for things you want.
If all this speaks to you, come join us on our journey!
Artiva Biotherapeutics is an equal employment opportunity employer.
Base Salary: $166,000 - $240,000. Exact compensation may vary based on skills and experience.
Artiva is clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers.
Artiva's lead product candidate, AlloNK, is a non-genetically modified, off-the-shelf, allogeneic, cryopreserved NK cell therapy designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell depletion and to be administered in the community setting. Unlike CAR-T and any genetically modified cell therapy, AlloNK is a non-genetically modified NK cell therapy candidate and has not shown any secondary malignancies in our clinical trials, which is a benefit in an autoimmunity setting. Using the company's proprietary cell therapy manufacturing platform, Artiva can generate thousands of doses of cryopreserved, infusion-ready AlloNK cells from a single cord blood unit. The FDA has granted Fast Track designation to AlloNK in combination with rituximab or obinutuzumab for the treatment of class III or IV lupus nephritis, and AlloNK in combination with rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma of B-cell origin (B-NHL).
AlloNK, is currently being evaluated in combination with B-cell targeted mAbs in
patients with autoimmune diseases and cancers, such as lupus nephritis, SLE, rheumatoid arthritis, pemphigus vulgaris, the ANCA-associated vasculitis subtypes GPA/MPA, and B-NHL. In addition, we are also pursuing AlloNK and our CAR-NK product candidates in multiple indications through collaborator-funded trials. Artiva's cell therapy manufacturing platform incorporates cell expansion and activation technology developed by Artiva's strategic partner, GC Cell Corporation, a member of the GC family of companies, a leading healthcare company in Korea.
Artiva is headquartered in San Diego and backed by leading venture investors including 5AM Ventures, RA Capital Management and venBio Partners.
For more information, visit www.artivabio.com.
Job Summary:
The Associate Director/Director of Medical Communications oversees the strategic planning and execution of all medical communication activities within Artiva.
Key Responsibilities:Develop strategies for effective scientific communication, ensuring compliance with industry standards and fostering scientific exchange.Drive the development and execution of high-quality medical publications, scientific content, medical education, medical information, and congress presentations.Act as a subject matter expert in communication landscape, HCP preferences, publication planning, data disclosure, and represent the organization's scientific communications externally.Demonstrate strong business acumen in managing the Medical Communications budget and allocating resources to highest business priorities.Collaborate effectively with internal and external disease-area experts to ensure high-quality data analysis, interpretation, and communication planning.Foster collaborative relationships with academic and clinical experts, medical associations, publishers, and other relevant stakeholders.Partner with third-party vendors to balance internal and external execution effectively.
Qualifications & Experience:Advanced scientific degree (PharmD, PhD.) preferred, with 7-10 years of experience in the pharmaceutical/healthcare industry focusing on medical communications.Experience in the autoimmunity therapeutic area preferred.Ability to communicate complex scientific concepts clearly through both written and oral channels; detail-oriented and data-driven.Proven track record in managing compliance requirements for medical education activities.Strong organizational, communication, facilitation, and interpersonal skills.Ability to analyze and interpret trial data effectively.Willingness and ability to travel as needed.
Why you should apply:
We have a fantastic team and philosophy! We are passionate - we deeply care about our team, our science, and improving the lives of cancer patients. We are tenacious - laser-focused on our mission and undeterred in our commitment to deliver life-saving medicines for cancer patients. We are innovative - pushing into new frontiers for patient benefit. We are transparent - believers in flat, accessible, and open communication paths. We are inclusive - committed to the diversity of our team and ensuring that all voices are heard.
In addition to a great culture, we offer:• A beautiful facility• An entrepreneurial, highly collaborative, and innovative environment• Comprehensive benefits, including:Medical, Dental, and VisionGroup Life InsuranceLong Term Disability (LTD)401(k) Retirement PlanEmployee Assistance Program (EAP)Flexible Spending Account (FSA)Paid Time Off (PTO)Company paid holidays, including the year-end holiday weekOur recognition program, Bonus.ly, is where you can trade in points earned for things you want.
If all this speaks to you, come join us on our journey!
Artiva Biotherapeutics is an equal employment opportunity employer.
Base Salary: $166,000 - $240,000. Exact compensation may vary based on skills and experience.